- The isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalisMuthenna Puppala
Department of Biochemistry, National Institute of Nutrition, Hyderabad, India
PLoS ONE 7:e31399. 2012..This study supports the continued development of natural products such as β-glucogallin as therapeutic leads in the development of novel therapies to treat diabetic complications such as cataract...
- The multicellular tumor spheroid model for high-throughput cancer drug discoveryDaniel V Labarbera
The University of Colorado Denver, The Skaggs School of Pharmacy and Pharmaceutical Sciences the University of Colorado AMC, The Department of Pharmaceutical Sciences, 12850 East Montview Blvd Aurora Colorado C238, USA
Expert Opin Drug Discov 7:819-30. 2012..Technological advances in 3D-cell culture models bridge the gap between 2D and in vivo models to improve upon the current success rates of cancer drug discovery...